Schering-plough Corp., Drugmaker | featured news

Merck to buy Schering-Plough in $41.1 billion deal

Merck to buy Schering-Plough in $41.1 billion deal

Drugmakers Merck & Co. and Schering-Plough Corp. are planning to merge under the name Merck in a stock-and-cash deal worth about $41.1 billion.

 

Subscribe to this RSS topic: Syndicate content